Artwork

Content provided by Focused Ultrasound Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Focused Ultrasound Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep27: How Histotripsy is Changing the Game: A Conversation with Zhen Xu, PhD

30:57
 
Share
 

Manage episode 475841957 series 3556445
Content provided by Focused Ultrasound Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Focused Ultrasound Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode of Curing with Sound, Zhen Xu, PhD, the Li Ka Shing Endowed Professor of Biomedical Engineering at the University of Michigan, discusses histotripsy. Dr. Xu and her colleagues developed histotripsy, the first noninvasive, nonthermal ultrasound ablation technique that received FDA approval for liver tumor treatment in 2023. Her work has led to multiple clinical trials on histotripsy treatment for malignant and benign tumors.

Dr. Xu shares the 20-year journey from initial discovery to clinical application and highlights histotripsy's remarkable ability to mechanically break down targeted tissue without incisions or radiation. She also recounts inspiring patient stories from clinical trials, including patients who experienced no pain and returned to normal activities immediately after treatment.

  • Regulatory Approval: In October 2023, the FDA cleared HistoSonics’ novel therapy platform, Edison™, to treat liver tumors. Edison™ uses histotripsy to noninvasively destroy liver tissue. This is the first time the use of histotripsy has earned regulatory approval worldwide.
  • The Science Behind Histotripsy: Dr. Xu explains how histotripsy uses focused ultrasound pulses to rapidly expand and collapse microbubbles that break down targeted cells with remarkable precision.
  • Future Directions: Dr. Xu envisions continued expansion of histotripsy applications over the next five years, including wider adoption for liver tumors, regulatory approvals for additional indications, and the development of new platforms for brain and shallow tumor treatments.

Histotripsy Lab: histotripsy.umich.edu
Connect on Linked In: Dr. Zhen Xu

EPISODE TRANSCRIPT
----------------------------
QUESTIONS?
Email [email protected] if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

Email [email protected] if you have questions about focused ultrasound or the Foundation.

FUSF SOCIAL MEDIA

FUSF WEBSITE
https://www.fusfoundation.org
SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/
READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/
DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

  continue reading

33 episodes

Artwork
iconShare
 
Manage episode 475841957 series 3556445
Content provided by Focused Ultrasound Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Focused Ultrasound Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode of Curing with Sound, Zhen Xu, PhD, the Li Ka Shing Endowed Professor of Biomedical Engineering at the University of Michigan, discusses histotripsy. Dr. Xu and her colleagues developed histotripsy, the first noninvasive, nonthermal ultrasound ablation technique that received FDA approval for liver tumor treatment in 2023. Her work has led to multiple clinical trials on histotripsy treatment for malignant and benign tumors.

Dr. Xu shares the 20-year journey from initial discovery to clinical application and highlights histotripsy's remarkable ability to mechanically break down targeted tissue without incisions or radiation. She also recounts inspiring patient stories from clinical trials, including patients who experienced no pain and returned to normal activities immediately after treatment.

  • Regulatory Approval: In October 2023, the FDA cleared HistoSonics’ novel therapy platform, Edison™, to treat liver tumors. Edison™ uses histotripsy to noninvasively destroy liver tissue. This is the first time the use of histotripsy has earned regulatory approval worldwide.
  • The Science Behind Histotripsy: Dr. Xu explains how histotripsy uses focused ultrasound pulses to rapidly expand and collapse microbubbles that break down targeted cells with remarkable precision.
  • Future Directions: Dr. Xu envisions continued expansion of histotripsy applications over the next five years, including wider adoption for liver tumors, regulatory approvals for additional indications, and the development of new platforms for brain and shallow tumor treatments.

Histotripsy Lab: histotripsy.umich.edu
Connect on Linked In: Dr. Zhen Xu

EPISODE TRANSCRIPT
----------------------------
QUESTIONS?
Email [email protected] if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

Email [email protected] if you have questions about focused ultrasound or the Foundation.

FUSF SOCIAL MEDIA

FUSF WEBSITE
https://www.fusfoundation.org
SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/
READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/
DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

  continue reading

33 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play